A new schedule of one week on/one week off temozolomide as second-line treatment of advanced neuroendocrine carcinomas (TENEC-TRIAL): a multicenter, open-label, single-arm, phase II trial
-
Published:2024-05
Issue:5
Volume:9
Page:103003
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
von Arx C.ORCID,
Della Vittoria Scarpati G.,
Cannella L.,
Clemente O.,
Marretta A.L.,
Bracigliano A.,
Picozzi F.,
Iervolino D.ORCID,
Granata V.,
Modica R.ORCID,
Bianco A.,
Mocerino C.,
Di Mauro A.,
Pizzolorusso A.,
Di Sarno A.,
Ottaiano A.,
Tafuto S.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献